Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

Repisalud
Publicación Artículo científico (JournalArticle)

Influence of Subclinical Atherosclerosis Burden and Progression on Mortality.

  • Fuster, Valentin
  • García-Álvarez, Ana
  • Devesa, Ana
  • Mass, Virginia
  • Owen, Ruth
  • Quesada, Antonio
  • Fuster, José J
  • García-Lunar, Inés
  • Pocock, Stuart
  • Sánchez-González, Javier
  • Sartori, Samantha
  • Peyra, Carlos
  • Andres, Vicente
  • Muntendam, Pieter
  • Ibanez, Borja
Atherosclerosis is a dynamic process. There is little evidence regarding whether quantification of atherosclerosis extent and progression, particularly in the carotid artery, in asymptomatic individuals predicts all-cause mortality. This study sought to evaluate the independent predictive value (beyond cardiovascular risk factors) of subclinical atherosclerosis burden and progression and all-cause mortality. A population of 5,716 asymptomatic U.S. adults (mean age 68.9 years, 56.7% female) enrolled between 2008 and 2009 in the BioImage (A Clinical Study of Burden of Atherosclerotic Disease in an At Risk Population) study underwent examination by vascular ultrasound to quantify carotid plaque burden (cPB) (the sum of right and left carotid plaque areas) and by computed tomography for coronary artery calcium (CAC). Follow-up carotid vascular ultrasound was performed on 732 participants a median of 8.9 years after the baseline exam. All participants were followed up for all-cause mortality, the primary outcome. Trend HRs are the per-tertile increase in each variable. Over a median 12.4 years' follow-up, 901 (16%) participants died. After adjustment for cardiovascular risk factors and background medication, baseline cPB and CAC score were both significantly associated with all-cause mortality (fully adjusted trend HR: 1.23; 95% CI: 1.16-1.32; and HR: 1.15; 95% CI: 1.08-1.23), respectively (both P < 0.001), thus providing additional prognostic value. cPB performed better than CAC score. In participants with a second vascular ultrasound evaluation, median cPB progressed from 29.2 to 91.3 mm. cPB progression was significantly associated with all-cause mortality after adjusting for cardiovascular risk factors and baseline cPB (HR: 1.03; 95% CI: 1.01-1.04 per absolute 10-mm change; P = 0.01). Subclinical atherosclerosis burden (cPB and CAC) in asymptomatic individuals was independently associated with all-cause mortality. Moreover, atherosclerosis progression was independently associated with all-cause mortality.
Repisalud
Publicación Artículo de revisión (ReviewArticle)

Right ventricular dysfunction: pathophysiology, experimental models, evaluation, and treatment.

  • Real, Carlos
  • Pérez-García, Carlos Nicolás
  • Galán-Arriola, Carlos
  • García-Lunar, Inés
  • García-Álvarez, Ana
Interest in the right ventricle has substantially increased due to advances in knowledge of its pathophysiology and prognostic implications across a wide spectrum of diseases. However, we are still far from understanding the multiple mechanisms that influence right ventricular dysfunction, its evaluation continues to be challenging, and there is a shortage of specific treatments in most scenarios. This review article aims to update knowledge about the physiology of the right ventricle, its transition to dysfunction, diagnostic tools, and available treatments from a translational perspective.
Repisalud
Publicación Artículo científico (JournalArticle)

Right ventricular dysfunction: pathophysiology, experimental models, evaluation, and treatment.

  • Real, Carlos
  • Pérez-García, Carlos Nicolás
  • Galán-Arriola, Carlos
  • García-Lunar, Inés
  • García-Álvarez, Ana
Interest in the right ventricle has substantially increased due to advances in knowledge of its pathophysiology and prognostic implications across a wide spectrum of diseases. However, we are still far from understanding the multiple mechanisms that influence right ventricular dysfunction, its evaluation continues to be challenging, and there is a shortage of specific treatments in most scenarios. This review article aims to update knowledge about the physiology of the right ventricle, its transition to dysfunction, diagnostic tools, and available treatments from a translational perspective.
RUA. Repositorio Institucional de la Universidad de Alicante
Publicación Otros (Other)

Elevated Plasma GDF-15 Levels are Associated with the Immune Non-Responder Phenotype in People with HIV

  • López López, Aida
  • Alonso Domínguez, Jacobo
  • Martínez Barros, Inés
  • Pérez González, Alexandre
  • Ocampo, Antonio
  • Morano, Luis
  • Martínez López de Castro, Noemí
  • Bisbal Pardo, Otilia
  • Díez, Cristina
  • Arcos-Rueda, Maria del Mar
  • Álvarez-Rodríguez, Ignacio
  • Portilla-Tamarit, Irene
  • Bernal-Morell, Enrique
  • López Cortés, Luis
  • Ruiz-Mateos, Ezequiel
  • Poveda, Eva
  • CoRIS cohort
  • Portilla-Tamarit, Irene|||/items/341962ea-60c0-459e-9454-90e3f9b71000
Introduction: Most people with HIV (PWH) achieve immune recovery with antiretroviral therapy (ART); however, a clinically relevant subset, known as immune non-responders (INRs), fails to restore CD4+ T-cell counts despite sustained virological suppression and shows persistent immune dysfunction. Growth differentiation factor 15 (GDF-15), a stress-responsive cytokine associated with inflammation, aging, chronic disease, and multimorbidity, has not been characterized across distinct HIV viro-immunological phenotypes. Methods: We conducted an exploratory cross-sectional study including 80 PWH classified as ART-naïve individuals, virally suppressed INRs, elite controllers (ECs), and ART-treated immune responders (IRs), as well as 20 HIV-negative controls. Plasma GDF-15 levels were measured by immunoassay. Associations with log-transformed GDF-15 concentrations were assessed using multivariable linear regression including age, CD4+ T-cell nadir, and INR status. Results: INRs showed the highest plasma GDF-15 levels (median, 1143.9 pg/ml), significantly exceeding those observed in ART-naïve individuals, ECs, IRs, and HIV-negative controls (all p ≤ 0.002). GDF-15 levels correlated positively with age, time since HIV diagnosis, and ART duration, and inversely with CD4+ T-cell nadir and the CD4/CD8 ratio (all p ≤ 0.001). In adjusted analysis, INR status remained independently associated with higher log-transformed GDF-15 levels (β = 0.271, 95% CI 0.062–0.480; p = 0.012), corresponding to 31.1% higher GDF-15 concentrations relative to non-INR participants. Conclusion: Plasma GDF-15 levels were higher in virally suppressed INRs than in other viro-immunological groups and remained independently associated with INR status after adjustment for selected covariates. These findings support further investigation of GDF-15 as a potential biomarker of incomplete immune recovery and residual biological stress in virally suppressed PWH. Prospective studies are warranted to validate its clinical and pathophysiological relevance.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

IP-10 and MIG are sensitive markers of early virological response to HIV-1 integrase inhibitors

  • Álvarez, Hortensia
  • Gutiérrez Valencia, Alicia
  • Mariño, Ana
  • Saborido-Alconchel, Abraham
  • Calderón-Cruz, Beatriz
  • Pérez-González, Alexandre
  • Alonso-Domínguez, Jacobo
  • Martínez-Barros, Inés
  • Gallego-Rodríguez, María
  • Moreno, Santiago
  • Aldámiz-Echevarría, Teresa
  • Montero-Alonso, Marta
  • Bernal, Enrique
  • Galera, Carlos
  • Llibre, Josep María
  • Poveda, Eva
  • CoRIS Study Group
© 2023 Álvarez, Gutiérrez-Valencia, Mariño, Saborido-Alconchel, Calderón-Cruz, Pérez-González, Alonso-Domínguez, Martínez-Barros, Gallego-Rodríguez, Moreno, Aldamiz, Montero-Alonso, Bernal, Galera, Llibre and Poveda. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms., Background: Interferon-inducible protein-10 (IP-10) and monokine induced by interferon-gamma (MIG) are chemokines recognized as inflammatory biomarkers during HIV-1 infection. We assessed their early and long-term dynamics after initiation of antiretroviral treatment (ART)., Methods: Persons with HIV-1 (PWH) aged>18 years starting their first ART in 2015-2021 in a prospective cohort (n=73) were included. IP-10 and MIG plasma levels were quantified using a multiplexed bead-based assay., Results: IP-10 and MIG plasma levels showed a significant and consistent reduction following ART (80% integrase inhibitor [INSTI]-based) initiation, starting at day 20 and maintained throughout the study period (48 months), paralleling the HIV-1 RNA decay and CD4+ count recovery (p<0·001). At baseline, PWH≥ 50 years, CDC stage C and CD4+ count<350cells/mm3 had higher levels of IP-10 (p=0·022, p=0·001 and p=0·002, respectively) and MIG (p<0·001, p=0·024 and p=0·069, respectively). All of them matched their counterparts several months following ART initiation. MIG levels showed a greater decrease at day 10 in those treated with INSTI (p=0·038). Low-level HIV-1 viremia did not impact MIG or IP-10 levels., Conclusion: Plasma IP-10 and MIG showed an early significant decline following ART initiation, with greater early declines in MIG levels in INSTI-based regimens. These findings suggest a strong impact of HIV-1 viremia on IP-10 and MIG levels., The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study has been funded by Instituto de Salud Carlos III [PI16/02159, BA18/00034, PI19/00747, PI22/01341, CM20/00243] and cofunded by the European Regional Development Fund, “A way to make Europe”; Red Española de Investigación en SIDA; Xunta de Galicia-Axencia Galega de Innovación (IN606A-2022/019); INVESTIGO Next GenerationEU Program TR349V-2022-10000052-00; Intramural Grant Program Galicia Sur Health Research Institute (CI22-A-2)., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Extrinsic contribution and instability properties in lead-based and lead-free piezoceramics

  • García García, José Eduardo
Piezoceramic materials generally exhibit a notable instability of their functional properties when they work under real external conditions. This undesirable effect, known as nonlinear behavior, is mostly associated with the extrinsic contribution to material response. In this article, the role of the ferroelectric domain walls' motion in the nonlinear response in the most workable lead-based and lead-free piezoceramics is reviewed. Initially, the extrinsic origin of the nonlinear response is discussed in terms of the temperature dependence of material response. The influence of the crystallographic phase and of the phase boundaries on the material response are then reviewed. Subsequently, the impact of the defects created by doping in order to control the extrinsic contribution is discussed as a way of tuning material properties. Finally, some aspects related to the grain-size effect on the nonlinear response of piezoceramics are surveyed., Peer Reviewed, Postprint (published version)